Suppr超能文献

子宫内膜异位症相关血管生成及子宫内膜异位症的抗血管生成治疗

Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis.

作者信息

Chung Monica S, Han Sang Jun

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Ob/Gyn, Baylor College of Medicine, Houston, TX, United States.

Laboratory of Dan L. Duncan Cancer Center and Reproductive Medicine, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.

出版信息

Front Glob Womens Health. 2022 Apr 5;3:856316. doi: 10.3389/fgwh.2022.856316. eCollection 2022.

Abstract

Endometriosis is a known estrogen-dependent inflammatory disease affecting reproductive-aged women. Common symptoms include pelvic pain, dysmenorrhea, dyspareunia, heavy menstrual bleeding, and infertility. The exact etiology of endometriosis is largely unknown, and, thus, the diagnosis and treatment of endometriosis are challenging. A complex interplay of many molecular mechanisms is thought to aid in the progression of endometriosis, most notably angiogenesis. This mini-review examines our current knowledge of the molecular etiology of endometriosis-associated angiogenesis and discusses anti-angiogenic therapy, in the blockade of endometriosis-associated angiogenesis, as potential non-hormonal therapy for the treatment of endometriosis.

摘要

子宫内膜异位症是一种已知的雌激素依赖性炎症性疾病,影响育龄妇女。常见症状包括盆腔疼痛、痛经、性交困难、月经过多和不孕。子宫内膜异位症的确切病因很大程度上尚不清楚,因此,子宫内膜异位症的诊断和治疗具有挑战性。许多分子机制之间复杂的相互作用被认为有助于子宫内膜异位症的进展,最显著的是血管生成。本综述探讨了我们目前对子宫内膜异位症相关血管生成分子病因的认识,并讨论了抗血管生成治疗,即在阻断子宫内膜异位症相关血管生成方面,作为治疗子宫内膜异位症的潜在非激素疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299f/9016174/220480968900/fgwh-03-856316-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验